Data443 Risk Mitigation (ATDS) 10-Q 14 Apr 21 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Mar. 31, 2021	Apr. 14, 2021
Cover [Abstract]
Entity Registrant Name	Data443 Risk Mitigation, Inc.
Entity Central Index Key	0001068689
Document Type	10-Q
Document Period End Date	Mar. 31, 2021
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	No
Entity Interactive Data Current	No
Entity Filer Category	Non-accelerated Filer
Entity Small Business Flag	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		1,427,565,404
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2021

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Current assets
Cash	$ 53,060	$ 58,783
Accounts receivable, net	36,911	136,503
Prepaid expense and other current assets	9,167
Total current assets	99,138	195,286
Property and equipment, net	367,612	324,349
Operating lease right-of-use assets, net	230,492	248,237
Intellectual property, net of accumulated amortization	2,069,385	2,310,907
Deposits	31,440	31,440
Total Assets	2,798,067	3,110,219
Current Liabilities
Accounts payable and accrued liabilities	383,654	401,014
Deferred revenue	1,255,396	1,478,430
Interest payable	29,012	62,212
Notes payable	826,173	585,310
Convertible notes payable, net of unamortized discount	89,264	1,241,412
Due to a related party	458,218	561,230
License fee payable		1,094,691
Operating lease liability	103,117	100,170
Finance lease liability	90,799	90,565
Total Current Liabilities	3,235,633	5,615,034
Series B Preferred Stock, 80,000 shares designated; $0.001 par value; Stated value $10.00 22,200 and 5,300 shares issued and outstanding, net of discount, respectively	211,438	50,203
Notes payable - non-current	1,873,093	572,495
Convertible notes payable, net of unamortized discount - non-current	7,287	2,356
Deferred revenues - non-current	31,657	39,733
Operating lease liability - non-current	210,715	237,961
Finance lease liability - non-current	61,237	83,109
Total Liabilities	5,631,060	6,600,891
Stockholders' Deficit
Preferred stock: 337,500 authorized; $0.001 par value Series A Preferred Stock, 150,000 shares designated; $0.001 par value; 150,000 shares issued and outstanding, respectively	150	150
Common stock: 1,800,000,000 authorized; $0.001 par value 1,442,053,442 and 1,044,012,947 shares issued and outstanding, respectively	1,442,053	1,044,013
Additional paid in capital	33,423,635	30,983,749
Accumulated deficit	(37,698,831)	(35,518,584)
Total Stockholders' Deficit	(2,832,993)	(3,490,672)
Total Liabilities and Stockholders' Deficit	$ 2,798,067	$ 3,110,219

Consolidated Balance Sheets (_2

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Mar. 31, 2021	Dec. 31, 2020
Temporary equity, shares authorized	80,000	80,000
Temporary equity, par value	$ 0.001	$ 0.001
Temporary equity, stated value	$ 10	$ 10
Temporary equity, shares issued	22,200	5,300
Temporary equity, shares outstanding	22,200	5,300
Preferred stock, shares authorized	337,500	337,500
Preferred stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	1,800,000,000	1,800,000,000
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares issued	1,442,053,442	1,044,012,947
Common stock, shares outstanding	1,442,053,442	1,044,012,947
Series A Preferred Stock [Member]
Preferred stock, shares authorized	150,000	150,000
Preferred stock, par value	$ 0.001	$ 0.001
Preferred stock, shares issued	150,000	150,000
Preferred stock, shares outstanding	150,000	150,000

Consolidated Statements of Oper

Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Income Statement [Abstract]
Revenue	$ 837,868	$ 477,877
Cost of revenue	166,994	34,289
Gross profit	670,874	443,588
Operating expenses
General and administrative	1,433,565	1,425,234
Sales and marketing	95,424	120,818
Total operating expenses	1,528,989	1,546,052
Net loss from operations	(858,115)	(1,102,464)
Other income (expense)
Interest expense	(905,426)	(518,400)
Loss on settlement of debt	(227,501)	(54,000)
Change in fair value of derivative liability	(185,256)	(8,506,151)
Total other expense	(1,318,183)	(9,078,551)
Loss before income taxes	(2,176,298)	(10,181,015)
Provision for income taxes
Net loss	(2,176,298)	(10,181,015)
Dividend on Series B Preferred Stock	(3,949)
Net loss attributable to common stockholders	$ (2,180,247)	$ (10,181,015)
Basic and diluted loss per Common Share	$ 0	$ (0.70)
Basic and diluted weighted average number of common shares outstanding	1,222,055,574	14,542,721

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Deficit (Unaudited) - USD ($)	Series A Preferred Stock [Member]	Common Stock [Member]	Additional Paid In Capital [Member]	Accumulated Deficit [Member]	Total
Balance at Dec. 31, 2019	$ 1	$ 9,692	$ 15,204,771	$ (21,610,915)	$ (6,396,451)
Balance, shares at Dec. 31, 2019	1,334	9,692,065
Common stock issued for conversion of debt		$ 6,824	1,317,686		1,324,510
Common stock issued for conversion of debt, shares		6,824,272
Common stock issued in conjunction with convertible note
Stock issued for asset acquisition		$ 2,466	(2,466)
Stock issued for asset acquisition, shares		2,465,754
Share-based compensation		$ 500	205,152		205,652
Stock-based compensation, shares		500,000
Net loss				(10,181,015)	(10,181,015)
Balance at Mar. 31, 2020	$ 1	$ 19,482	16,725,143	(31,791,930)	(15,047,304)
Balance, shares at Mar. 31, 2020	1,334	19,482,091
Balance at Dec. 31, 2020	$ 150	$ 1,044,013	30,983,749	(35,518,584)	(3,490,672)
Balance, shares at Dec. 31, 2020	150,000	1,044,012,947
Common stock issued for cash		$ 166,667	486,938		653,605
Common stock issued for cash, shares		166,666,667
Common stock issued for conversion of preferred stock		$ 11,196	157,011		168,207
Common stock issued for conversion of preferred stock, shares		11,196,474
Common stock issued for conversion of debt		$ 203,494	1,319,764		1,523,258
Common stock issued for conversion of debt, shares		203,494,048
Common stock issued in conjunction with convertible note		$ 5,725	83,013		88,738
Common stock issued in conjunction with convertible note, shares		5,725,000
Share-based compensation		$ 10,958	393,160		404,118
Stock-based compensation, shares		10,958,306
Net loss				(2,180,247)	(2,180,247)
Balance at Mar. 31, 2021	$ 150	$ 1,442,053	$ 33,423,635	$ (37,698,831)	$ (2,832,993)
Balance, shares at Mar. 31, 2021	150,000	1,442,053,442

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (2,180,247)	$ (10,181,015)
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of derivative liability	185,256	8,506,151
Loss on settlement of debt	227,501	54,000
Stock-based compensation expense	404,118	205,652
Depreciation and amortization	277,279	450,359
Amortization of debt discount	838,227	437,639
Bad debt		50,800
Lease liability amortization	(6,554)	(2,128)
Changes in operating assets and liabilities:
Accounts receivable	99,592	(18,610)
Prepaid expenses and other assets	(9,167)	242
Accounts payable and accrued liabilities	(16,901)	(70,841)
Deferred revenue	(231,110)	192,947
Payroll liability		(10,535)
Accrued interest	28,358	52,999
Deposit		(10,496)
Net Cash used in Operating Activities	(383,648)	(342,836)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment	(79,020)	(4,068)
Net Cash used in Investing Activities	(79,020)	(4,068)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from issuance of convertible notes payable	100,000	497,250
Proceeds from issuance of common stock	653,605
Proceeds from issuance of series B Preferred Stock	160,000
Finance lease payments	(21,638)	(8,225)
Proceeds from issuance of notes payable	924,581	189,615
Repayment of notes payable	(1,256,591)	(203,245)
Proceeds from related parties	65,250	83,204
Repayment to related parties	(168,262)	(160,725)
Net Cash provided by Financing Activities	456,945	397,874
Net change in cash	(5,723)	50,970
Cash, beginning of period	58,783	18,673
Cash, end of period	53,060	69,643
Supplemental cash flow information
Cash paid for interest	15,101	27,653
Cash paid for taxes
Non-cash Investing and Financing transactions:
Settlement of series B preferred stock through issuance of common stock	168,207
Settlement of convertible notes payable through issuance of common stock	1,523,258	427,671
Common stock issued in conjunction with convertible note	88,738
Resolution of derivative liability upon conversion of debt		896,839
Equipment paid by capital lease		158,005
Derivative liability recognized as debt discount	100,000	500,675
Settlement of convertible notes payable through issuance of preferred common stock	65,600
Note payable issued for settlement of License fee payable	$ 1,404,000

Summary of Significant Accounti

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	NOTE 1: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements as of March 31, 2021 include the accounts of the Company and its wholly-owned subsidiary, Data 443 Risk Mitigation, Inc., a North Carolina operating company, and the operations of Myriad Software Productions, LLC through September 2018 when it was liquidated. Prior to the acquisition of Data 443 Risk Mitigation, Inc. in North Carolina and the assets of Myriad Software Productions, LLC in 2018, these two entities were controlled by our sole director and officer, Jason Remillard. On November 17, 2017, Mr. Remillard acquired control of LandStar, Inc. through his purchase of all the outstanding Series A preferred shares of the Company, and as a result, these two entities became common controlled entities that require consolidation of results with the reporting company, LandStar, Inc., from the time common control occurred. All intercompany accounts and activities have been eliminated. These consolidated financial statements have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). Interim Financial Statements These unaudited consolidated financial statements have been prepared in accordance U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2020 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the “SEC”) on March 23, 2021. The results of operations for the three months ended March 31, 2021, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2021. Share-Based Compensation Employees Nonemployees Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting The Company recorded approximately $404,118 in share-based compensation expense for the three months ended March 31, 2021, compared to $205,652 in share-based compensation expense for the three months ended March 31, 2020. Determining the appropriate fair value model and the related assumptions requires judgment. During the three months ended March 31, 2021, the fair value of each option grant was estimated using a Black-Scholes option-pricing model. The expected volatility represents the historical volatility of the Company’s publicly traded common stock. Due to limited historical data, the Company calculates the expected life based on the mid-point between the vesting date and the contractual term which is in accordance with the simplified method. The expected term for options granted to nonemployees is the contractual life. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of stock options. The Company has not paid and does not anticipate paying cash dividends on its shares of common stock; therefore, the expected dividend yield is assumed to be zero. Basic and Diluted Net Loss Per Common Share Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and as if converted method. Dilutive potential common shares include outstanding stock options, warrant and convertible notes. For the three months ended March 31, 2021 and 2020, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2021 2020 (Shares) (Shares) Series A Preferred Stock 150,000,000 1,334,000 Stock options 24,942,045 466,672 Warrants 100,000,000 69,714,754 Convertible notes - 144,106,172 Total 261,327,991 215,621,598 Recently Issued Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with “Conversion and Other Options” and ASC subtopic 815-40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its consolidated financial statements.

Liquidity and Going Concern

Liquidity and Going Concern	3 Months Ended
	Mar. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Liquidity and Going Concern	NOTE 2: LIQUIDITY AND GOING CONCERN The accompanying consolidated financial statements have been prepared (i) in accordance with accounting principles generally accepted in the United States, and (ii) assuming that the Company will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company has not generated significant income to date. The Company is subject to the risks and uncertainties associated with a business with no substantive revenue, as well as limitations on its operating capital resources. These matters, among others, raise substantial doubt about the ability of the Company to continue as a going concern. These consolidated financial statements do not include any adjustments to the amounts and classification of assets and liabilities that may be necessary should the Company be unable to continue as a going concern. In light of these matters, the Company’s ability to continue as a going concern is dependent upon the Company’s ability to raise capital and generate revenue and profits in the future. During 2018, the Company made two product acquisitions, ClassiDocs™, and ARALOC ™ Data443 ™ We continue to monitor the effects COVID-19 could have on our operations and liquidity including our ability to collect account receivable timely from our customers due to the economic impacts COVID-19 could have on the general economy. COVID-19 has also impacted our ability to travel, meet distribution partners in their offices, present at tradeshows, and perform other enterprise-related sales functions. Many customers have still yet to return to their pre-pandemic “normal” office working conditions. These continued operating conditions have impacted our ability to execute and deploy some of our normal sales and marketing activities. While we are not unique in this position, these factors, among others, raise some doubt about the Company’s ability to continue as a going concern. The accompanying consolidated financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Property and Equipment	NOTE 3: PROPERTY AND EQUIPMENT The following table summarizes the components of the Company’s property and equipment as of the dates presented: March 31, December 31, 2021 2020 Furniture and Fixtures $ 2,991 $ 2,991 Computer Equipment 500,343 421,323 503,334 424,314 Accumulated depreciation (135,722 ) (99,965 ) Property and equipment, net of accumulated depreciation $ 367,612 $ 324,349 Depreciation expense for the three months ended March 31, 2021 and 2020, was $35,757 and $11,421, respectively. During the three months years ended March 31, 2021 and 2020, the Company purchased property and equipment of $79,020 and $4,068, respectively.

Intellectual Property

Intellectual Property	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Intellectual Property	NOTE 4: INTELLECTUAL PROPERTY The following table summarizes the components of the Company’s intellectual property as of the dates presented: March 31, December 31, 2021 2020 Intellectual property: Word press GDPR rights $ 46,800 $ 46,800 ARALOC™ 1,850,000 1,850,000 ArcMail License 1,445,000 1,445,000 DataExpress TM 1,388,051 1,388,051 FileFacets TM 135,000 135,000 IntellyWP™ 135,000 135,000 Resilient Network Systems 305,000 305,000 5,304,851 5,304,851 Accumulated amortization (3,235,466 ) (2,993,944 ) Intellectual property, net of accumulated amortization $ 2,069,385 $ 2,310,907 The Company recognized amortization expense of approximately $241,522 and $438,938 for the three months ended March 31, 2021, and 2020, respectively. Based on the carrying value of definite-lived intangible assets as of March 31, 2021, we estimate our amortization expense for the next five years will be as follows: Amortization Year Ended December 31, Expense 2021 (excluding the three months ended March 31, 2021) $ 724,566 2022 860,484 2023 441,584 2024 27,000 Thereafter 15,750 2,069,385

Accounts Payable and Accrued Li

Accounts Payable and Accrued Liabilities	3 Months Ended
	Mar. 31, 2021
Payables and Accruals [Abstract]
Accounts Payable and Accrued Liabilities	NOTE 5: ACCOUNTS PAYABLE AND ACCRUED LIABILITIES The following table summarizes the components of the Company’s accounts payable and accrued liabilities as of the dates presented: March 31, December 31, 2021 2019 Accounts payable $ 191,177 $ 178,319 Payroll liabilities 106,513 102,793 Credit cards 42,657 31,918 Accrued dividend - preferred stock 3,307 484 Accrued liabilities 40,000 87,500 $ 383,654 $ 401,014

Deferred Revenue

Deferred Revenue	3 Months Ended
	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Deferred Revenue	NOTE 6: DEFERRED REVENUE Changes in deferred revenue were as follows: March 31, 2020 Balance, beginning of period $ 1,518,163 Deferral of revenue 508,358 Recognition of deferred revenue (739,468 ) Balance, end of period $ 1,287,053 March 31, December 31, 2020 2020 Current $ 1,255,396 $ 1,478,430 Non-current 31,657 39,733 $ 1,287,053 $ 1,518,163

Leases

Leases	3 Months Ended
	Mar. 31, 2021
Leases [Abstract]
Leases	NOTE 7: LEASES Operating lease We have noncancelable operating leases for our office facility that expire in 2024. The operating lease has renewal options and rent escalation clauses. We recognized total lease expense of approximately $24,000 and $28,000 for the three months ended March 31, 2021 and 2020, respectively, primarily related to operating lease costs paid to lessors from operating cash flows. As of March 31, 2021 and December 31, 2020, the Company recorded security deposit of $10,000. We entered into our operating lease in January 2019. On July 1, 2020, the Company renegotiated the office lease to obtain rent expense relief for the months of April 2020 – December 2020. Future minimum lease payments under operating leases that have initial noncancelable lease terms in excess of one year at March 31, 2021 were as follows: Total Year Ended December 31, 2021 (excluding the three months ended March 31, 2021) $ 92,700 2022 127,300 2023 131,150 Thereafter - 351,150 Less: Imputed interest (37,318 ) Operating lease liabilities 313,832 Operating lease liability - current 103,117 Operating lease liability - non-current $ 210,715 The following summarizes other supplemental information about the Company’s operating lease as of March 31, 2021: Weighted average discount rate 8 % Weighted average remaining lease term (years) 2.79 Finance lease The Company leases computer and hardware under non-cancellable capital lease arrangements. The term of those capital leases is 3 years and annual interest rate is 12%. At March 31, 2021 and December 31, 2020, capital lease obligations included in current liabilities were $90,799 and $90,565, respectively, and capital lease obligations included in long-term liabilities were $61,237 and $83,109, respectively. As of March 31, 2021 and December 31, 2020, the Company recorded security deposit of $10,944. At March 31, 2021, future minimum lease payments under the finance lease obligations, are as follows: Total 2021 (excluding the three months ended March 31, 2021) $ 79,899 2022 78,379 2023 10,496 Thereafter - 168,774 Less: Imputed interest (16,738 ) Finance lease liabilities 152,036 Finance lease liability 90,799 Finance lease liability - non-current $ 61,237 As of March 31, 2021 and December 31, finance lease assets are included in property and equipment as follows: March 31, December 31, 2021 2020 Finance lease assets $ 267,284 $ 267,284 Accumulated depreciation (106,912 ) (87,337 ) Finance lease assets, net of accumulated depreciation $ 160,372 $ 179,947

Convertible Notes Payable

Convertible Notes Payable	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Convertible Notes Payable	NOTE 8: CONVERTIBLE NOTES PAYABLE Convertible notes payable consists of the following: March 31, December 31, 2021 2020 Convertible Notes - Issued in fiscal year 2020 100,000 1,526,000 Convertible Notes - Issued in fiscal year 2021 114,500 - 214,500 1,526,000 Less debt discount and debt issuance cost (117,949 ) (282,232 ) 96,551 1,243,768 Less current portion of convertible notes payable 89,264 1,243,768 Long-term convertible notes payable $ 7,287 $ - During the three months ended March 31, 2021 and 2020, the Company recognized interest expense of $15,142 and $53,517, and amortization of debt discount, included in interest expense of $305,441 and $410,019, respectively. Conversion During the three months ended March 31, 2021, the Company converted notes with principal amounts and accrued interest of $1,340,150 into 203,494,048 shares of common stock. The corresponding derivative liability at the date of conversion of $183,108 was credited to additional paid in capital. Convertible notes payable consists of the following: Promissory Notes - Issued in fiscal year 2020 During the twelve months ended December 31, 2020, the Company issued a total of $2,466,500 of notes with the following terms: ● Terms ranging from 5 months to 60 months. ● Annual interest rates of 0% - 25%. ● Convertible at the option of the holders at issuance date, after maturity date or 6 months after issuance date. ● Conversion prices are typically based on the discounted (25% to 50% discount) average closing prices or lowest trading prices of the Company’s shares during various periods prior to conversion. Certain note has a fixed conversion price ranging from $0.001 to $0.007. Certain note has a fixed conversion price of $0.5 for a first 5 months Certain note allows the principal amount will increase by $15,000 and the discount rate of conversion price will decrease by 18% if the conversion price is less than $$0.01. Promissory Notes - Issued during first three months of fiscal year 2021 During the three months ended March 31, 2021, the Company issued convertible note of $114,500 for cash proceeds of $100,000 after deducting financing fee of $14,500 with the following terms; ● Terms 90 days. ● Annual interest rates of 5%. ● Convertible at the option of the holders after maturity date ● Conversion price is the lesser of (i) $0.01 or (ii) 61% multiplied by the average of two lowest trading prices during the 20 trading day period prior to the conversion date. ● 5,725,000 shares of common stock valued at $88,738 issued in conjunction with convertible note

Derivative Liabilities

Derivative Liabilities	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Liabilities	NOTE 9: DERIVATIVE LIABILITIES The Company analyzed the conversion option for derivative accounting consideration under ASC 815, Derivatives and Hedging, and hedging, and determined that the instrument should be classified as a liability since the conversion option becomes effective at issuance resulting in there being no explicit limit to the number of shares to be delivered upon settlement of the above conversion options. ASC 815 requires we assess the fair market value of derivative liability at the end of each reporting period and recognize any change in the fair market value as other income or expense item. The Company determined our derivative liabilities to be a Level 3 fair value measurement during the year based on management’s estimate of the expected future cash flows required to settle the liabilities, and used the Binomial pricing model to calculate the fair value as of March 31, 2021. As of the three month period ended March 31, 2021, there were no derivative liabilities. The Binomial model requires six basic data inputs: the exercise or strike price, time to expiration, the risk-free interest rate, the current stock price, the estimated volatility of the stock price in the future, and the dividend rate. Changes to these inputs could produce a significantly higher or lower fair value measurement. The fair value of each convertible note and warrant is estimated using the Binomial valuation model. For the three months March 31, 2021 and 2020, the estimated fair values of the liabilities measured on a recurring basis are as follows: The Company valued the conversion feature using the Binomial pricing model. The fair value of the derivative liability for all the notes and convertible preferred stock that became convertible, including the notes and convertible preferred stock issued in prior years, during the three months ended March 31, 2021 amounted to $186,456, and $100,000 of the value assigned to the derivative liability was recognized as a debt discount to the notes, while the balance of $86,459 was recognized as a “day 1” derivative loss. For the three months March 31, 2021 and year ended December 31, 2020, the estimated fair values of the liabilities measured on a recurring basis are as follows: Three months Ended Year Ended March 31, December 31, 2021 2020 Expected term 0.48 - 1.00 years 0.25 - 5.00 years Expected average volatility 186%- 302% 187%- 464% Expected dividend yield - - Risk-free interest rate 0.07% - 0.10% 0.01% - 1.57% The following table summarizes the changes in the derivative liabilities during the three months March 31, 2021 and 2021: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Derivative liability as of December 31, 2020 $ - Addition of new derivatives recognized as debt discounts 100,000 Addition of new derivatives recognized as day-one loss 86,459 Derivative liabilities settled upon conversion of convertible note (285,256 ) Change in derivative liabilities recognized as loss on derivative 98,797 Derivative liability as of March 31, 2021 $ - The aggregate loss on derivatives during the three months ended March 31, 2021 and 2020 was $185,256 and $8,506,151, respectively.

Notes Payable

Notes Payable	3 Months Ended
	Mar. 31, 2021
Notes Payable [Abstract]
Notes Payable	NOTE 10: NOTES PAYABLE Notes payable consists of the following: March 31, December 31, 2021 2020 Maturity Interest Rate 10% Promissory note - originated in October 2019 $ 25,060 $ 25,060 Due on demand 10.0 % Promissory note - originated in October 2019 25,060 25,060 Due on demand 10.0 % Promissory note - originated in April 2020 10,000 10,000 Due on demand No interest Paycheck Protection Program Promissory note - originated in April 2020 (1) 339,000 339,000 2 years 1.0 % Economic Injury Disaster Loan - originated in May 2020 (2) 150,000 150,000 30 years 1.0 % Promissory note - originated in June 2020 - 43,356 $3,942.86 daily payment 16.0 % Promissory note - originated in September 2020 73,162 80,730 $2,873.89 monthly payment for 36 months 14.0 % Promissory note - originated in October 2020 - 158,169 $2,293.31 daily payment 25.0 % Promissory note - originated in November 2020 - 170,886 $4,497.00 daily payment 25.0 % Promissory note - originated in November 2020 439,243 394,846 $6,999.00 daily payment 25.0 % Promissory note - originated in December 2020 47,199 50,031 $1,854.41 monthly payment for 36 months 8.0 % Promissory note - originated in January 2021 (3) 1,394,000 - 5 years 4.0 % Promissory note - originated in January 2021 68,338 - $2,675.89 monthly payment for 36 months 18.0 % Promissory note - originated in January 2021 14,484 - $992.06 daily payment 25.0 % Promissory note - originated in January 2021 112,425 - $4,497.00 daily payment 25.0 % Promissory note - originated in February 2021 171,224 - $3,971.43 daily payment 25.0 % Promissory note - originated in March 2021 73,950 - $870,00 daily payment 15.0 % Promissory note - originated in March 2021 47,595 - $5,613.46 daily payment 24.0 % 2,990,740 1,447,138 Less debt discount and debt issuance cost (291,474 ) (289,332 ) 2,699,266 1,157,806 Less current portion of promissory notes payable 826,173 585,310 Long-term promissory notes payable $ 1,873,093 $ 572,496 (1) In response to the Coronavirus (COVID-19) pandemic, the US Government passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act on March 27, 2020. The CARES Act provides fast and direct economic assistance for entrepreneurs and small businesses through the US Small Business Administration (“SBA”). During the period, the Company received a loan issued under the CARES Act program - Paycheck Protection Program (“PPP”). This loan program provides small businesses with funds to pay up to 8 weeks of payroll costs including benefits. Funds can also be used to pay interest on mortgages, rent, and utilities. Under the PPP, the Company may apply to have certain amounts forgiven under the direction of the Administrator of the SBA providing that the Company satisfies certain criteria. Repayment of the PPP loan will commence earlier of when the SBA remits the forgiveness amount to the lender or the Maturity Date. (2) The Company received an advance under the Economic Injury Disaster Loan (EIDL) program. As the Company received an EIDL advance and a PPP loan, the EIDL advance portion will be applied against the PPP forgiveness amount as repayment to the SBA upon approval of the PPP forgiveness application. (3) On February 12, 2021, the Company issued notes payable of $1,404,000 to settle license fee payable of $1,094,691. As a result, the Company recorded loss on settlement of debt of $309,309. During the three months ended March 31, 2021, the Company recognized interest expense of $17,170, and amortization of debt discount, included in interest expense of $469,471, respectively. During the three months years ended March 31, 2021 and 2020, the Company issued a total of $2,800,191 and $276,000, less discount of $471,610 and $86,385, and repaid $1,256,591 and $203,245, respectively.

Capital Stock and Reverse Stock

Capital Stock and Reverse Stock Split	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Capital Stock and Reverse Stock Split	NOTE 11: CAPITAL STOCK AND REVERSE STOCK SPLIT Changes in Authorized Shares On February 19, 2021 the written consent of the holders of a majority of the voting power of the outstanding capital stock of the Company as of the Record Date (the “Consenting Stockholders”) approved the following corporate actions: (1) Amendment of our articles of incorporation (the “Articles of Incorporation”) to provide for a decrease in the authorized shares of the Company’s Common Stock from 1,800,000,000 to a number of not less than 10,000,000 and not more than 1,000,000,000 (the “Authorized Common Stock Reduction”), at any time prior to the one year anniversary of the filing of the Definitive Information Statement on Schedule 14C with respect to the actions envisioned under Preliminary Information Statement in Schedule 14C filed with the SEC on February 23 2021 (the “Definitive Information Statement”), with the Board of Directors of the Company (the “Board”) having the discretion to determine whether or not the Authorized Common Stock Reduction is to be effected, and if effected, the exact number of the Authorized Common Stock Reduction within the above range. (2) That the Board be authorized to implement through the amendment to our Articles of Incorporation a reverse stock split of the Company’s Common Stock by a ratio of not less than 1-for-10 and not more than 1-for-2,000, (the “Reverse Split”), at any time prior to the one year anniversary of the filing of the Definitive Information Statement, with the Board having the discretion to determine whether or not the Reverse Split is to be effected, and if effected, the exact ratio for the Reverse Split within the above range. Preferred Stock Series A Preferred Stock As of March 31, 2021 and December 31, 2020, 150,000 shares of Series A were issued and outstanding. Each share of Series A was (i) convertible into 1,000 shares of common stock, and (ii) entitled to vote 15,000 shares of common stock on all matters submitted to a vote by shareholders voting common stock. All issued and outstanding shares of Series A Preferred Stock are held by Mr. Jason Remillard, sole director of the Company. Series B Preferred Stock As of March 31, 2021 and December 31, 2020, 22,200 and 5,300 shares of Series B were issued and outstanding, respectively. Each share of Series B (i) has a stated value of Ten Dollars ($10.00) per share; (ii) are convertible into common stock at a price per share equal to sixty one percent (61%) of the lowest price for the Company’s common stock during the twenty (20) day of trading preceding the date of the conversion; (iii) earn dividends at the rate of nine percent (9%) per annum; and, (iv) generally have no voting rights. During the three months ended March 31, 2021, the Company issued a total of 23,460 shares of Series B preferred stock as follows ● 16,900 shares for $160,000, less $9,000 financing fee. ● 6,560 shares in exchange for convertible note and accrued interest of $65,600 During the three months ended March 31, 2021, 6,560 shares of series B preferred stock was converted into 11,196,475 shares. Common Stock As of March 31, 2021, the Company is authorized to issue 1,800,000,000 shares of common stock with a par value of $0.001. All shares have equal voting rights, are non-assessable, and have one vote per share. The total number of shares of Company common stock issued and outstanding as of March 31, 2021 and December 31, 2020, respectively, was 1,442,053,442 and 1,044,012,947 shares, respectively. During the three months ended March 31, 2021, the Company issued common stock as follows: ● 203,494,048 shares issued for conversion of debt; ● 166,666,667 shares issued for cash of 1,000,000, less financing cost of $10,000, of which $336,395 was not yet received,; ● 10,958,306 shares issued for service ● 11,196,474 shares issued for conversion of Series B preferred stock; and ● 5,725,000 shares issued as a loan fee in connection with the issuance of a promissory note. Warrants During the three month period ended March 31, 2021 the Company did not issue any warrants. A summary of activity during the period ended March 31, 2021 follows: Warrants Outstanding Weighted Average Shares Exercise Price Outstanding, December 31, 2020 100,000,000 $ 0.01 Granted - Reset feature Exercised - - Forfeited/canceled - - Outstanding, March 31, 2021 100,000,000 $ 0.01 The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2021: Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life Weighted Average Number of Weighted Average Shares (in years) Exercise Price Shares Exercise Price 100,000,000 4.70 $ 0.0100 100,000,000 $ 0.0100

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	NOTE 12: SHARE-BASED COMPENSATION Stock Options During the three months ended March 31, 2021, the Company granted options for the purchase of the Company’s common stock to certain employees, consultants and advisors as consideration for services rendered. The terms of the stock option grants are determined by the Company’s Board of Directors. The Company’s stock options generally vest upon the one-year anniversary date of the grant and have a maximum term of ten years. The following summarizes the stock option activity for the three months ended March 31, 2021: Weighted-Average Options Outstanding Exercise Price Balance as of December 31, 2020 11,751,592 $ 0.05 Grants 13,190,453 0.02 Exercised - - Cancelled - - Balance as of Mach 31, 2021 24,942,045 $ 0.03 The weighted average grant date fair value of stock options granted during the three months ended March 31, 2021 was $0.0215. The total fair value of stock options that granted during the three ended March 31, 2021 was approximately $284,000. The fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted average assumptions for stock options granted during the three months ended March 31, 2021: Expected term (years) 5.7 years Expected stock price volatility 296.17 % Weighted-average risk-free interest rate 0.64 % Expected dividend $ 0.00 Volatility is a measure of the amount by which a financial variable such as share price has fluctuated (historical volatility) or is expected to fluctuate (expected volatility) during a period. The Company estimates expected volatility giving primary consideration to the historical volatility of its common stock. The risk-free interest rate is based on the published yield available on U.S. Treasury issues with an equivalent term remaining equal to the expected life of the stock option. The expected lives of the stock options represent the estimated period of time until exercise or forfeiture and are based on the simplified method of using the mid-point between the vesting term and the original contractual term. The following summarizes certain information about stock options vested and expected to vest as of March 31, 2021: Weighted-Average Number of Remaining Contractual Life Weighted- Average Options (In Years) Exercise Price Outstanding 24,942,045 9.58 $ 0.03 Exercisable 745,031 8.81 0.43 Expected to vest 24,197,014 9.60 $ 0.02 As of March 31, 2021 and December 31, 2020, there was $448,292 and $211,661, respectively, of total unrecognized compensation cost related to non-vested share-based compensation arrangements which is expected to be recognized within the next year. Restricted Stock Awards During the three months ended March 31, 2021, the Company issued restricted stock awards for shares of common stock which have been reserved for the holders of the awards. Restricted stock awards were issued to certain consultants and advisors as consideration for services rendered. The terms of the restricted stock units are determined by the Company’s Board of Directors. The Company’s restricted stock shares generally vest over a period of one year and have a maximum term of ten years. The following summarizes the restricted stock activity for the three months ended March 31, 2021: Weighted-Average Shares Fair Value Balance as of December 31, 2020 14,712,760 0.02 Shares of restricted stock granted 9,000,309 0.03 Exercised - - Cancelled - - Balance as of Mach 31, 2021 23,713,069 0.04 March 31, December 31, Number of Restricted Stock Awards 2021 2020 Vested 477,192 452,192 Non-vested 23,235,877 14,260,568 As of March 31, 2021 and December 31, 2020, there was $245,619 and $144,964, respectively, of total unrecognized compensation cost related to non-vested share-based compensation, which is expected to be recognized over the next year.

Related Party Transactions

Related Party Transactions	3 Months Ended
	Mar. 31, 2021
Related Party Transactions [Abstract]
Related Party Transactions	NOTE 13: RELATED PARTY TRANSACTIONS Jason Remillard is our Chief Executive Officer and sole director. Through his ownership of Series A Preferred Shares, Mr. Remillard has voting control over all matters to be submitted to a vote of our shareholders. On September 16, 2019, the Company entered into an Asset Purchase Agreement with DMBGroup, LLC. Amounts owed to DMBGroup, LLC including the note payable of $940,000 and member loans of $97,689 were recorded as amounts due to a related party. During the three months ended March 31, 2021, the Company repaid note payable of $119,499 including interest expense of $5,485. As of March 31, 2021 and December 31, 2020, the Company had recorded a liability to DMBGroup totaling $285,883 and $405,382, respectively. During the three months ended March 31, 2021, the Company borrowed $47,000 from our CEO, our CEO paid operating expenses of $18,249 on behalf of the Company and the Company repaid $48,763 to our CEO. As of March 31, 2021 and December 31, 2020, the Company had due to related party of $458,218 and $561,230, respectively.

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2021
Subsequent Events [Abstract]
Subsequent Events	NOTE 14: SUBSEQUENT EVENTS The Company has analyzed its operations subsequent to March 31, 2021 through the date these financial statements were issued and has determined that it does not have any material subsequent events to disclose.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Basis of Presentation and Principles of Consolidation	Basis of Presentation and Principles of Consolidation The accompanying consolidated financial statements as of March 31, 2021 include the accounts of the Company and its wholly-owned subsidiary, Data 443 Risk Mitigation, Inc., a North Carolina operating company, and the operations of Myriad Software Productions, LLC through September 2018 when it was liquidated. Prior to the acquisition of Data 443 Risk Mitigation, Inc. in North Carolina and the assets of Myriad Software Productions, LLC in 2018, these two entities were controlled by our sole director and officer, Jason Remillard. On November 17, 2017, Mr. Remillard acquired control of LandStar, Inc. through his purchase of all the outstanding Series A preferred shares of the Company, and as a result, these two entities became common controlled entities that require consolidation of results with the reporting company, LandStar, Inc., from the time common control occurred. All intercompany accounts and activities have been eliminated. These consolidated financial statements have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”).
Interim Financial Statements	Interim Financial Statements These unaudited consolidated financial statements have been prepared in accordance U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X. Accordingly, the consolidated financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and such adjustments are of a normal recurring nature. These consolidated financial statements should be read in conjunction with the consolidated financial statements for the year ended December 31, 2020 and notes thereto and other pertinent information contained in our Form 10-K the Company has filed with the Securities and Exchange Commission (the “SEC”) on March 23, 2021. The results of operations for the three months ended March 31, 2021, are not necessarily indicative of the results to be expected for the full fiscal year ending December 31, 2021.
Share-Based Compensation	Share-Based Compensation Employees Nonemployees Compensation-Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting The Company recorded approximately $404,118 in share-based compensation expense for the three months ended March 31, 2021, compared to $205,652 in share-based compensation expense for the three months ended March 31, 2020. Determining the appropriate fair value model and the related assumptions requires judgment. During the three months ended March 31, 2021, the fair value of each option grant was estimated using a Black-Scholes option-pricing model. The expected volatility represents the historical volatility of the Company’s publicly traded common stock. Due to limited historical data, the Company calculates the expected life based on the mid-point between the vesting date and the contractual term which is in accordance with the simplified method. The expected term for options granted to nonemployees is the contractual life. The risk-free interest rate is based on a treasury instrument whose term is consistent with the expected life of stock options. The Company has not paid and does not anticipate paying cash dividends on its shares of common stock; therefore, the expected dividend yield is assumed to be zero.
Basic and Diluted Net Loss Per Common Share	Basic and Diluted Net Loss Per Common Share Basic earnings per share (“EPS”) is computed based on the weighted average number of shares of common stock outstanding during the period. Diluted EPS is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method and as if converted method. Dilutive potential common shares include outstanding stock options, warrant and convertible notes. For the three months ended March 31, 2021 and 2020, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2021 2020 (Shares) (Shares) Series A Preferred Stock 150,000,000 1,334,000 Stock options 24,942,045 466,672 Warrants 100,000,000 69,714,754 Convertible notes - 144,106,172 Total 261,327,991 215,621,598
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements In August 2020, the FASB issued ASU 2020-06, ASC Subtopic 470-20 “Debt—Debt with “Conversion and Other Options” and ASC subtopic 815-40 “Hedging—Contracts in Entity’s Own Equity”. The standard reduced the number of accounting models for convertible debt instruments and convertible preferred stock. Convertible instruments that continue to be subject to separation models are (1) those with embedded conversion features that are not clearly and closely related to the host contract, that meet the definition of a derivative, and that do not qualify for a scope exception from derivative accounting; and, (2) convertible debt instruments issued with substantial premiums for which the premiums are recorded as paid-in capital. The amendments in this update are effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. Early adoption is permitted, but no earlier than fiscal years beginning after December 15, 2020, including interim periods within those fiscal years. The Company is currently assessing the impact of the adoption of this standard on its consolidated financial statements. The Company has considered all other recently issued accounting pronouncements and does not believe the adoption of such pronouncements will have a material impact on its consolidated financial statements.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2021
Accounting Policies [Abstract]
Schedule of Anti-dilutive Basic and Diluted Earnings Per Share	For the three months ended March 31, 2021 and 2020, respectively, the following common stock equivalents were excluded from the computation of diluted net loss per share as the result of the computation was anti-dilutive. March 31, 2021 2020 (Shares) (Shares) Series A Preferred Stock 150,000,000 1,334,000 Stock options 24,942,045 466,672 Warrants 100,000,000 69,714,754 Convertible notes - 144,106,172 Total 261,327,991 215,621,598

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2021
Property, Plant and Equipment [Abstract]
Summary of Components of Property and Equipment	The following table summarizes the components of the Company’s property and equipment as of the dates presented: March 31, December 31, 2021 2020 Furniture and Fixtures $ 2,991 $ 2,991 Computer Equipment 500,343 421,323 503,334 424,314 Accumulated depreciation (135,722 ) (99,965 ) Property and equipment, net of accumulated depreciation $ 367,612 $ 324,349

Intellectual Property (Tables)

Intellectual Property (Tables)	3 Months Ended
	Mar. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Intellectual Property	The following table summarizes the components of the Company’s intellectual property as of the dates presented: March 31, December 31, 2021 2020 Intellectual property: Word press GDPR rights $ 46,800 $ 46,800 ARALOC™ 1,850,000 1,850,000 ArcMail License 1,445,000 1,445,000 DataExpress TM 1,388,051 1,388,051 FileFacets TM 135,000 135,000 IntellyWP™ 135,000 135,000 Resilient Network Systems 305,000 305,000 5,304,851 5,304,851 Accumulated amortization (3,235,466 ) (2,993,944 ) Intellectual property, net of accumulated amortization $ 2,069,385 $ 2,310,907
Schedule of Future Amortization Expense of Intangible Assets	Based on the carrying value of definite-lived intangible assets as of March 31, 2021, we estimate our amortization expense for the next five years will be as follows: Amortization Year Ended December 31, Expense 2021 (excluding the three months ended March 31, 2021) $ 724,566 2022 860,484 2023 441,584 2024 27,000 Thereafter 15,750 2,069,385

Accounts Payable and Accrued _2

Accounts Payable and Accrued Liabilities (Tables)	3 Months Ended
	Mar. 31, 2021
Payables and Accruals [Abstract]
Summary of Accounts Payable and Accrued Liabilities	The following table summarizes the components of the Company’s accounts payable and accrued liabilities as of the dates presented: March 31, December 31, 2021 2019 Accounts payable $ 191,177 $ 178,319 Payroll liabilities 106,513 102,793 Credit cards 42,657 31,918 Accrued dividend - preferred stock 3,307 484 Accrued liabilities 40,000 87,500 $ 383,654 $ 401,014

Deferred Revenue (Tables)

Deferred Revenue (Tables)	3 Months Ended
	Mar. 31, 2021
Revenue from Contract with Customer [Abstract]
Summary of Deferred Revenue	Changes in deferred revenue were as follows: March 31, 2020 Balance, beginning of period $ 1,518,163 Deferral of revenue 508,358 Recognition of deferred revenue (739,468 ) Balance, end of period $ 1,287,053 March 31, December 31, 2020 2020 Current $ 1,255,396 $ 1,478,430 Non-current 31,657 39,733 $ 1,287,053 $ 1,518,163

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2021
Leases [Abstract]
Schedule of Future Minimum Lease Payments Under Operating Leases	Future minimum lease payments under operating leases that have initial noncancelable lease terms in excess of one year at March 31, 2021 were as follows: Total Year Ended December 31, 2021 (excluding the three months ended March 31, 2021) $ 92,700 2022 127,300 2023 131,150 Thereafter - 351,150 Less: Imputed interest (37,318 ) Operating lease liabilities 313,832 Operating lease liability - current 103,117 Operating lease liability - non-current $ 210,715
Schedule of Other Supplemental Information Under Operating Lease	The following summarizes other supplemental information about the Company’s operating lease as of March 31, 2021: Weighted average discount rate 8 % Weighted average remaining lease term (years) 2.79
Schedule of Future Minimum Lease Payments Under Finance Leases	At March 31, 2021, future minimum lease payments under the finance lease obligations, are as follows: Total 2021 (excluding the three months ended March 31, 2021) $ 79,899 2022 78,379 2023 10,496 Thereafter - 168,774 Less: Imputed interest (16,738 ) Finance lease liabilities 152,036 Finance lease liability 90,799 Finance lease liability - non-current $ 61,237
Schedule of Finance Lease Assets	As of March 31, 2021 and December 31, finance lease assets are included in property and equipment as follows: March 31, December 31, 2021 2020 Finance lease assets $ 267,284 $ 267,284 Accumulated depreciation (106,912 ) (87,337 ) Finance lease assets, net of accumulated depreciation $ 160,372 $ 179,947

Convertible Notes Payable (Tabl

Convertible Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2021
Debt Disclosure [Abstract]
Schedule of Convertible Notes Payable	Convertible notes payable consists of the following: March 31, December 31, 2021 2020 Convertible Notes - Issued in fiscal year 2020 100,000 1,526,000 Convertible Notes - Issued in fiscal year 2021 114,500 - 214,500 1,526,000 Less debt discount and debt issuance cost (117,949 ) (282,232 ) 96,551 1,243,768 Less current portion of convertible notes payable 89,264 1,243,768 Long-term convertible notes payable $ 7,287 $ -

Derivative Liabilities (Tables)

Derivative Liabilities (Tables)	3 Months Ended
	Mar. 31, 2021
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Fair Value of Liabilities Measured on Recurring Basis	For the three months March 31, 2021 and year ended December 31, 2020, the estimated fair values of the liabilities measured on a recurring basis are as follows: Three months Ended Year Ended March 31, December 31, 2021 2020 Expected term 0.48 - 1.00 years 0.25 - 5.00 years Expected average volatility 186%- 302% 187%- 464% Expected dividend yield - - Risk-free interest rate 0.07% - 0.10% 0.01% - 1.57%
Schedule of Changes in Derivative Liabilities	The following table summarizes the changes in the derivative liabilities during the three months March 31, 2021 and 2021: Fair Value Measurements Using Significant Unobservable Inputs (Level 3) Derivative liability as of December 31, 2020 $ - Addition of new derivatives recognized as debt discounts 100,000 Addition of new derivatives recognized as day-one loss 86,459 Derivative liabilities settled upon conversion of convertible note (285,256 ) Change in derivative liabilities recognized as loss on derivative 98,797 Derivative liability as of March 31, 2021 $ -

Notes Payable (Tables)

Notes Payable (Tables)	3 Months Ended
	Mar. 31, 2021
Notes Payable [Abstract]
Schedule of Notes Payable	Notes payable consists of the following: March 31, December 31, 2021 2020 Maturity Interest Rate 10% Promissory note - originated in October 2019 $ 25,060 $ 25,060 Due on demand 10.0 % Promissory note - originated in October 2019 25,060 25,060 Due on demand 10.0 % Promissory note - originated in April 2020 10,000 10,000 Due on demand No interest Paycheck Protection Program Promissory note - originated in April 2020 (1) 339,000 339,000 2 years 1.0 % Economic Injury Disaster Loan - originated in May 2020 (2) 150,000 150,000 30 years 1.0 % Promissory note - originated in June 2020 - 43,356 $3,942.86 daily payment 16.0 % Promissory note - originated in September 2020 73,162 80,730 $2,873.89 monthly payment for 36 months 14.0 % Promissory note - originated in October 2020 - 158,169 $2,293.31 daily payment 25.0 % Promissory note - originated in November 2020 - 170,886 $4,497.00 daily payment 25.0 % Promissory note - originated in November 2020 439,243 394,846 $6,999.00 daily payment 25.0 % Promissory note - originated in December 2020 47,199 50,031 $1,854.41 monthly payment for 36 months 8.0 % Promissory note - originated in January 2021 (3) 1,394,000 - 5 years 4.0 % Promissory note - originated in January 2021 68,338 - $2,675.89 monthly payment for 36 months 18.0 % Promissory note - originated in January 2021 14,484 - $992.06 daily payment 25.0 % Promissory note - originated in January 2021 112,425 - $4,497.00 daily payment 25.0 % Promissory note - originated in February 2021 171,224 - $3,971.43 daily payment 25.0 % Promissory note - originated in March 2021 73,950 - $870,00 daily payment 15.0 % Promissory note - originated in March 2021 47,595 - $5,613.46 daily payment 24.0 % 2,990,740 1,447,138 Less debt discount and debt issuance cost (291,474 ) (289,332 ) 2,699,266 1,157,806 Less current portion of promissory notes payable 826,173 585,310 Long-term promissory notes payable $ 1,873,093 $ 572,496 (1) In response to the Coronavirus (COVID-19) pandemic, the US Government passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act on March 27, 2020. The CARES Act provides fast and direct economic assistance for entrepreneurs and small businesses through the US Small Business Administration (“SBA”). During the period, the Company received a loan issued under the CARES Act program - Paycheck Protection Program (“PPP”). This loan program provides small businesses with funds to pay up to 8 weeks of payroll costs including benefits. Funds can also be used to pay interest on mortgages, rent, and utilities. Under the PPP, the Company may apply to have certain amounts forgiven under the direction of the Administrator of the SBA providing that the Company satisfies certain criteria. Repayment of the PPP loan will commence earlier of when the SBA remits the forgiveness amount to the lender or the Maturity Date. (2) The Company received an advance under the Economic Injury Disaster Loan (EIDL) program. As the Company received an EIDL advance and a PPP loan, the EIDL advance portion will be applied against the PPP forgiveness amount as repayment to the SBA upon approval of the PPP forgiveness application. (3) On February 12, 2021, the Company issued notes payable of $1,404,000 to settle license fee payable of $1,094,691. As a result, the Company recorded loss on settlement of debt of $309,309.

Capital Stock and Reverse Sto_2

Capital Stock and Reverse Stock Split (Tables)	3 Months Ended
	Mar. 31, 2021
Equity [Abstract]
Summary of Warrants Activity	A summary of activity during the period ended March 31, 2021 follows: Warrants Outstanding Weighted Average Shares Exercise Price Outstanding, December 31, 2020 100,000,000 $ 0.01 Granted - Reset feature Exercised - - Forfeited/canceled - - Outstanding, March 31, 2021 100,000,000 $ 0.01
Schedule of Outstanding and Exercisable Warrants	The following table summarizes information relating to outstanding and exercisable warrants as of March 31, 2021: Warrants Outstanding Warrants Exercisable Number of Weighted Average Remaining Contractual life Weighted Average Number of Weighted Average Shares (in years) Exercise Price Shares Exercise Price 100,000,000 4.70 $ 0.0100 100,000,000 $ 0.0100

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Schedule of Stock Option Activity	The following summarizes the stock option activity for the three months ended March 31, 2021: Weighted-Average Options Outstanding Exercise Price Balance as of December 31, 2020 11,751,592 $ 0.05 Grants 13,190,453 0.02 Exercised - - Cancelled - - Balance as of Mach 31, 2021 24,942,045 $ 0.03
Schedule of Weighted Average Assumptions for Stock Options Granted	The fair value of each stock option is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted average assumptions for stock options granted during the three months ended March 31, 2021: Expected term (years) 5.7 years Expected stock price volatility 296.17 % Weighted-average risk-free interest rate 0.64 % Expected dividend $ 0.00
Schedule of Stock Options Vested and Expected to Vest	The following summarizes certain information about stock options vested and expected to vest as of March 31, 2021: Weighted-Average Number of Remaining Contractual Life Weighted- Average Options (In Years) Exercise Price Outstanding 24,942,045 9.58 $ 0.03 Exercisable 745,031 8.81 0.43 Expected to vest 24,197,014 9.60 $ 0.02
Schedule of Restricted Stock Activity	The following summarizes the restricted stock activity for the three months ended March 31, 2021: Weighted-Average Shares Fair Value Balance as of December 31, 2020 14,712,760 0.02 Shares of restricted stock granted 9,000,309 0.03 Exercised - - Cancelled - - Balance as of Mach 31, 2021 23,713,069 0.04
Schedule of Restricted Stock Award	March 31, December 31, Number of Restricted Stock Awards 2021 2020 Vested 477,192 452,192 Non-vested 23,235,877 14,260,568

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Accounting Policies [Abstract]
Share-based compensation expense	$ 404,118	$ 205,652

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Schedule of Anti-dilutive Basic and Diluted Earnings Per Share (Details) - shares	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Antidilutive Earnings Per Share	261,327,991	215,621,598
Stock Options [Member]
Antidilutive Earnings Per Share	24,942,045	466,672
Warrants [Member]
Antidilutive Earnings Per Share	100,000,000	69,714,754
Convertible Notes [Member]
Antidilutive Earnings Per Share		144,106,172
Series A Preferred Stock [Member]
Antidilutive Earnings Per Share	150,000,000	1,334,000

Property and Equipment (Details

Property and Equipment (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Property, Plant and Equipment [Abstract]
Depreciation expense	$ 35,757	$ 11,421
Payments to purchased property and equipment	$ 79,020	$ 4,068

Property and Equipment - Summar

Property and Equipment - Summary of Components of Property and Equipment (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Property and equipment, gross	$ 503,334	$ 424,314
Accumulated depreciation	(135,722)	(99,965)
Property and equipment, net of accumulated depreciation	367,612	324,349
Furniture and Fixtures [Member]
Property and equipment, gross	2,991	2,991
Computer Equipment [Member]
Property and equipment, gross	$ 500,343	$ 421,323

Intellectual Property (Details

Intellectual Property (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization expense	$ 241,522	$ 438,938

Intellectual Property - Schedul

Intellectual Property - Schedule of Intellectual Property (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Intellectual property	$ 5,304,851	$ 5,304,851
Accumulated amortization	(3,235,466)	(2,993,944)
Intellectual property, net of accumulated amortization	2,069,385	2,310,907
Word Press GDPR Rights [Member]
Intellectual property	46,800	46,800
ARALOC [Member]
Intellectual property	1,850,000	1,850,000
ArcMail License [Member]
Intellectual property	1,445,000	1,445,000
Data Express [Member]
Intellectual property	1,388,051	1,388,051
FileFacets [Member]
Intellectual property	135,000	135,000
IntellyWP [Member]
Intellectual property	135,000	135,000
Resilien Network Systems [Member]
Intellectual property	$ 305,000	$ 305,000

Intellectual Property - Sched_2

Intellectual Property - Schedule of Future Amortization Expense of Intangible Assets (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
2021 (excluding the three months ended March 31, 2021)	$ 724,566
2022	860,484
2023	441,584
2024	27,000
Thereafter	15,750
Intellectual property, net of accumulated amortization	$ 2,069,385	$ 2,310,907

Accounts Payable and Accrued _3

Accounts Payable and Accrued Liabilities - Summary of Accounts Payable and Accrued Liabilities (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Payables and Accruals [Abstract]
Accounts payable	$ 191,177		$ 178,319
Payroll liabilities	106,513		102,793
Credit cards	42,657		31,918
Accrued dividend - preferred stock	3,307		484
Accrued liabilities	40,000		87,500
Accounts payable and accrued liabilities	$ 383,654	$ 401,014	$ 401,014

Deferred Revenue - Summary of D

Deferred Revenue - Summary of Deferred Revenue (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2021	Dec. 31, 2020
Revenue from Contract with Customer [Abstract]
Balance, beginning of period	$ 1,518,163
Deferral of revenue	508,358
Recognition of deferred revenue	(739,468)
Balance, end of period	1,287,053
Current		$ 1,255,396	$ 1,478,430
Non-current		31,657	39,733
Deferred revenue	$ 1,287,053	$ 1,287,053	$ 1,518,163

Leases (Details Narrative)

Leases (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Leases [Abstract]
Operating lease expire year	Operating leases for our office facility that expire in 2024
Recognized lease expense	$ 24,000	$ 28,000
Security deposit	$ 10,000		$ 10,000
Capital lease term			3 years
Capital leases annual interest rate	12.00%
Capital lease obligations current	$ 90,799		$ 90,565
Capital lease obligations noncurrent	61,237		83,109
Finance lease security deposit	$ 10,944		$ 10,944

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments Under Operating Leases (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2021 (excluding the three months ended March 31, 2021)	$ 92,700
2022	127,300
2023	131,150
Thereafter
Total lease payment	351,150
Less: Imputed interest	(37,318)
Operating lease liabilities	313,832
Operating lease liability - current	103,117	$ 100,170
Operating lease liability - non-current	$ 210,715	$ 237,961

Leases - Schedule of Other Supp

Leases - Schedule of Other Supplemental Information Under Operating Lease (Details)	Mar. 31, 2021
Leases [Abstract]
Weighted average discount rate	8.00%
Weighted average remaining lease term (years)	2 years 9 months 14 days

Leases - Schedule of Future M_2

Leases - Schedule of Future Minimum Lease Payments Under Finance Leases (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
2021 (excluding the three months ended March 31, 2021)	$ 79,899
2022	78,379
2023	10,496
Thereafter
Total finance lease payment	168,774
Less: Imputed interest	(16,738)
Finance lease liabilities	152,036
Finance lease liability - current	90,799	$ 90,565
Finance lease liability - non-current	$ 61,237	$ 83,109

Leases - Schedule of Finance Le

Leases - Schedule of Finance Lease Assets (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Finance lease assets	$ 267,284	$ 267,284
Accumulated depreciation	(106,912)	(87,337)
Finance lease assets, net of accumulated depreciation	$ 160,372	$ 179,947

Convertible Notes Payable (Deta

Convertible Notes Payable (Details Narrative) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Interest expense	$ 15,142	$ 53,517
Amortization of debt discount	838,227	437,639
Derivative liability	100,000
Convertible outstanding amount	96,551		$ 1,243,768
Proceeds from convertible debt	100,000	497,250
Financing fee	10,000
Common stock issued for conversion, value	1,523,258	1,324,510
Convertible Note [Member]
Amortization of debt discount	305,441	$ 410,019
Debt converted into common stock	$ 1,340,150
Debt converted into common stock, shares	203,494,048
Derivative liability	$ 183,108
Common stock issued for conversion, shares	5,725,000
Common stock issued for conversion, value	$ 88,738
Promissory Notes - Issued in Fiscal Year 2020 [Member]
Convertible outstanding amount			$ 2,466,500
Debt instrument maturity date, description			Convertible at the option of the holders at issuance date, after maturity date or 6 months after issuance date.
Debt conversion, description			Conversion prices are typically based on the discounted (25% to 50% discount) average closing prices or lowest trading prices of the Company's shares during various periods prior to conversion. Certain note has a fixed conversion price ranging from $0.001 to $0.007. Certain note has a fixed conversion price of $0.5 for a first 5 months Certain note allows the principal amount will increase by $15,000 and the discount rate of conversion price will decrease by 18% if the conversion price is less than $$0.01.
Promissory Notes - Issued in Fiscal Year 2020 [Member] | Minimum [Member]
Debt instrument term			5 months
Debt interest rate			25.00%
Promissory Notes - Issued in Fiscal Year 2020 [Member] | Maximum [Member]
Debt instrument term			60 months
Debt interest rate			50.00%
Promissory Notes - Issued During First Three Months of Fiscal Year 2021 [Member]
Convertible outstanding amount	$ 114,500
Debt instrument term	90 days
Debt interest rate	5.00%
Debt instrument maturity date, description	Convertible at the option of the holders after maturity date
Debt conversion, description	Conversion price is the lesser of (i) $0.01 or (ii) 61% multiplied by the average of two lowest trading prices during the 20 trading day period prior to the conversion date.
Proceeds from convertible debt	$ 100,000
Financing fee	$ 14,500

Convertible Notes Payable - Sch

Convertible Notes Payable - Schedule of Convertible Notes Payable (Details) - USD ($)	Mar. 31, 2021	Dec. 31, 2020
Convertible notes payable, Gross	$ 214,500	$ 1,526,000
Less debt discount and debt issuance cost	(117,949)	(282,232)
Convertible notes payable	96,551	1,243,768
Less current portion of convertible notes payable	89,264	1,243,768
Long-term convertible notes payable	7,287
Issued in Fiscal Year 2020 [Member]
Convertible notes payable, Gross	100,000	1,526,000
Issued in Fiscal Year 2021 [Member]
Convertible notes payable, Gross	$ 114,500

Derivative Liabilities (Details

Derivative Liabilities (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of derivative liability	$ 186,456
Derivative liability	100,000
Loss on derivative	86,459
Aggregate loss on derivatives	$ (185,256)	$ (8,506,151)

Derivative Liabilities - Schedu

Derivative Liabilities - Schedule of Fair Value of Liabilities Measured on Recurring Basis (Details)	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Expected Dividend Yield [Member]
Derivative liability, measurement input, percentage	0	0
Minimum [Member] | Measurement Input, Expected Term [Member]
Expected term	5 months 23 days	2 months 30 days
Minimum [Member] | Expected Average Volatility [Member]
Derivative liability, measurement input, percentage	186	187
Minimum [Member] | Risk Free Interest Rate [Member]
Derivative liability, measurement input, percentage	0.07	0.01
Maximum [Member] | Measurement Input, Expected Term [Member]
Expected term	1 year	5 years
Maximum [Member] | Expected Average Volatility [Member]
Derivative liability, measurement input, percentage	302	464
Maximum [Member] | Risk Free Interest Rate [Member]
Derivative liability, measurement input, percentage	0.10	1.57

Derivative Liabilities - Sche_2

Derivative Liabilities - Schedule of Changes in Derivative Liabilities (Details) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Change in derivative liabilities recognized as loss on derivative	$ (185,256)	$ (8,506,151)
Derivative liability ending	100,000
Fair Value, Inputs, Level 3 [Member]
Derivative liability beginning
Addition of new derivatives recognized as debt discounts	100,000
Addition of new derivatives recognized as day-one loss	86,459
Derivative liabilities settled upon conversion of convertible note	(285,256)
Change in derivative liabilities recognized as loss on derivative	98,797
Derivative liability ending

Notes Payable (Details Narrativ

Notes Payable (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Interest expense	$ 15,142	$ 53,517
Amortization of debt discount	838,227	437,639
Note issued	924,581	189,615
Repayment of notes payable	1,256,591	203,245
Notes Payable [Member]
Interest expense	17,170
Amortization of debt discount	469,471
Note issued	2,800,191	276,000
Debt discount	471,610	86,385
Repayment of notes payable	$ 1,256,591	$ 203,245

Notes Payable - Schedule of Not

Notes Payable - Schedule of Notes Payable (Details) - USD ($)		3 Months Ended	12 Months Ended
		Mar. 31, 2021	Dec. 31, 2020
Promissory notes payable, Gross		$ 2,990,740	$ 1,447,138
Less debt discount and debt issuance cost		(291,474)	(289,332)
Promissory notes payable		2,699,266	1,157,806
Less current portion of Promissory notes payable		826,173	585,310
Long-term Promissory notes payable		1,873,093	572,495
10% Promissory Note - Originated In October 2019 [Member]
Promissory notes payable, Gross		$ 25,060	$ 25,060
Maturity		Due on demand	Due on demand
Interest Rate		10.00%	10.00%
Promissory Note - Originated In October 2019 One [Member]
Promissory notes payable, Gross		$ 25,060	$ 25,060
Maturity		Due on demand	Due on demand
Interest Rate		10.00%	10.00%
Promissory Note - Originated In April 2020 [Member]
Promissory notes payable, Gross		$ 10,000	$ 10,000
Maturity		Due on demand	Due on demand
Interest Rate		0.00%	0.00%
Paycheck Protection Program Promissory Note - Originated In April 2020 [Member]
Promissory notes payable, Gross	[1]	$ 339,000	$ 339,000
Maturity		2 years	2 years
Interest Rate		1.00%	1.00%
Economic Injury Disaster Loan - Originated In May 2020 [Member]
Promissory notes payable, Gross	[2]	$ 150,000	$ 150,000
Maturity		30 years	30 years
Interest Rate		1.00%	1.00%
Promissory Note - Originated In June 2020 [Member]
Promissory notes payable, Gross			$ 43,356
Interest Rate			16.00%
Daily/monthly payment			$ 3,943
Promissory Note - Originated In September 2020 [Member]
Promissory notes payable, Gross		$ 73,162	$ 80,730
Maturity		36 months	36 months
Interest Rate		14.00%	14.00%
Daily/monthly payment		$ 2,874	$ 2,874
Promissory Note - Originated In October 2020 [Member]
Promissory notes payable, Gross			$ 158,169
Interest Rate			25.00%
Daily/monthly payment			$ 2,293
Promissory Note - Originated In November 2020 [Member]
Promissory notes payable, Gross			$ 170,886
Interest Rate			25.00%
Daily/monthly payment			$ 4,497
Promissory Note - Originated In November 2020 [Member]
Promissory notes payable, Gross		$ 439,243	$ 394,846
Interest Rate		25.00%	25.00%
Daily/monthly payment		$ 6,999	$ 6,999
Promissory Note - Originated In December 2020 [Member]
Promissory notes payable, Gross		$ 47,199	$ 50,031
Maturity		36 months	36 months
Interest Rate		8.00%	8.00%
Daily/monthly payment		$ 1,854	$ 1,854
Promissory Note - Originated In January 2021 [Member]
Promissory notes payable, Gross	[3]	$ 1,394,000
Maturity		5 years
Interest Rate		4.00%
Promissory Note - Originated In January 2021 [Member]
Promissory notes payable, Gross		$ 68,338
Maturity		36 months
Interest Rate		18.00%
Daily/monthly payment		$ 2,676
Promissory Note - Originated In January 2021 [Member]
Promissory notes payable, Gross		$ 14,484
Interest Rate		25.00%
Daily/monthly payment		$ 992
Promissory Note - Originated In January 2021 [Member]
Promissory notes payable, Gross		$ 112,425
Interest Rate		25.00%
Daily/monthly payment		$ 4,497
Promissory Note - Originated In February 2021 [Member]
Promissory notes payable, Gross		$ 171,224
Interest Rate		25.00%
Daily/monthly payment		$ 3,971
Promissory Note - Originated In March 2021 [Member]
Promissory notes payable, Gross		$ 73,950
Interest Rate		15.00%
Daily/monthly payment		$ 870
Promissory Note - Originated In March 2021 [Member]
Promissory notes payable, Gross		$ 47,595
Interest Rate		24.00%
Daily/monthly payment		$ 5,613
[1]	In response to the Coronavirus (COVID-19) pandemic, the US Government passed the Coronavirus Aid, Relief, and Economic Security (CARES) Act on March 27, 2020. The CARES Act provides fast and direct economic assistance for entrepreneurs and small businesses through the US Small Business Administration ("SBA"). During the period, the Company received a loan issued under the CARES Act program - Paycheck Protection Program ("PPP"). This loan program provides small businesses with funds to pay up to 8 weeks of payroll costs including benefits. Funds can also be used to pay interest on mortgages, rent, and utilities. Under the PPP, the Company may apply to have certain amounts forgiven under the direction of the Administrator of the SBA providing that the Company satisfies certain criteria. Repayment of the PPP loan will commence earlier of when the SBA remits the forgiveness amount to the lender or the Maturity Date.
[2]	The Company received an advance under the Economic Injury Disaster Loan (EIDL) program. As the Company received an EIDL advance and a PPP loan, the EIDL advance portion will be applied against the PPP forgiveness amount as repayment to the SBA upon approval of the PPP forgiveness application.
[3]	On February 12, 2021, the Company issued notes payable of $1,404,000 to settle license fee payable of $1,094,691. As a result, the Company recorded loss on settlement of debt of $309,309.

Notes Payable - Schedule of N_2

Notes Payable - Schedule of Notes Payable (Details) (Parenthetical) - USD ($)	Feb. 12, 2021	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Notes Payable [Abstract]
Note payable issued for settlement of License fee payable	$ 1,404,000	$ 1,404,000
License fee payable	1,094,691			$ 1,094,691
Loss on loan settlement	$ 309,309	$ (227,501)	$ (54,000)

Capital Stock and Reverse Sto_3

Capital Stock and Reverse Stock Split (Details Narrative) - USD ($)	Feb. 19, 2021	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020
Common stock, shares authorized	1,800,000,000	1,800,000,000		1,800,000,000
Reverse stock split	Not less than 1-for-10 and not more than 1-for-2,000
Stock issued during period, value		$ 653,605
Financing fee		$ 10,000
Common stock, par value		$ 0.001		$ 0.001
Common stock voting rights		one vote per share
Common stock, shares issued		1,442,053,442		1,044,012,947
Common stock, shares outstanding		1,442,053,442		1,044,012,947
Stock issued during period, unreceived value		$ 336,395
Shares issued for service		10,958,306
Number of warrants issued
Promissory Notes - Issued During First Three Months of Fiscal Year 2021 [Member]
Shares issued during the period		5,725,000
Financing fee		$ 14,500
Shares Issuance for Cash [Member]
Shares issued during the period		166,666,667
Shares Issued for Conversion of Debt [Member]
Stock issued for conversion of debt		203,494,048
Series A Preferred Stock [Member]
Preferred stock, shares issued		150,000		150,000
Preferred stock, shares outstanding		150,000		150,000
Debt converted of common stock, shares		1,000		1,000
Preferred stock voting rights		Entitled to vote 15,000 shares of common stock on all matters submitted to a vote by shareholders voting common stock.		Entitled to vote 15,000 shares of common stock on all matters submitted to a vote by shareholders voting common stock.
Shares issued during the period
Stock issued during period, value
Stock issued for conversion of debt
Series B Preferred Stock [Member]
Preferred stock, shares issued		22,200		5,300
Preferred stock, shares outstanding		22,200		5,300
Preferred stock, stated value		$ 10		$ 10
Preferred stock, description		Each share of Series B (i) has a stated value of Ten Dollars ($10.00) per share; (ii) are convertible into common stock at a price per share equal to sixty one percent (61%) of the lowest price for the Company's common stock during the twenty (20) day of trading preceding the date of the conversion; (iii) earn dividends at the rate of nine percent (9%) per annum; and, (iv) generally have no voting rights.
Preferred stock, dividend rate		9.00%
Shares issued during the period		23,460
Stock issued for conversion of debt		6,560
Accrued interest		$ 65,600
Stock issued for conversion		11,196,475
Series B Preferred Stock [Member] | Issuance of Shares [Member]
Shares issued during the period		16,900
Stock issued during period, value		$ 160,000
Financing fee		$ 9,000
Minimum [Member]
Common Stock, Authorized Reduction	10,000,000
Maximum [Member]
Common Stock, Authorized Reduction	1,000,000,000

Capital Stock and Reverse Sto_4

Capital Stock and Reverse Stock Split - Summary of Warrants Activity (Details)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Equity [Abstract]
Warrants Outstanding Beginning balance, Shares | shares	100,000,000
Warrants Granted, Shares | shares
Warrants Reset feature, Shares | shares
Warrants Exercised, Shares | shares
Warrants Forfeited/canceled, Shares | shares
Warrants Outstanding Ending balance, Shares | shares	100,000,000
Warrants Outstanding Beginning balance, Weighted Average Exercise Price | $ / shares	$ 0.01
Warrants Granted, Weighted Average Exercise Price | $ / shares
Warrants Reset feature, Weighted Average Exercise Price | $ / shares
Warrants Exercised, Weighted Average Exercise Price | $ / shares
Warrants Forfeited/canceled, Weighted Average Exercise Price | $ / shares
Warrants Outstanding Ending balance, Weighted Average Exercise Price | $ / shares	$ 0.01

Capital Stock and Reverse Sto_5

Capital Stock and Reverse Stock Split - Schedule of Outstanding and Exercisable Warrants (Details) - $ / shares	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Equity [Abstract]
Number of Shares, Warrants Outstanding	100,000,000	100,000,000
Weighted Average Remaining Contractual life, Warrants Outstanding	4 years 8 months 12 days
Weighted Average Exercise Price, Warrants Outstanding	$ 0.0100
Number of Shares, Warrants Exercisable	100,000,000
Weighted Average Exercise Price, Warrants Exercisable	$ 0.0100

Share-Based Compensation (Detai

Share-Based Compensation (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Restricted Stock [Member]
Unrecognized compensation and non-vested	$ 245,619	$ 144,964
Stock Options [Member]
Share-based compensation, vesting period	1 year
Weighted average granted date fair value stock options granted	$ 0.0215
Fair value of option vested	$ 284,000
Unrecognized compensation and non-vested	$ 448,292	$ 211,661
Stock Options [Member] | Maximum [Member]
Share-based compensation, expiration term	10 years

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of Stock Option Activity (Details) - Employees Consultants and Advisors [Member]	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Options Outstanding, Balance Beginning | shares	11,751,592
Options Outstanding, Grants | shares	13,190,453
Options Outstanding, Exercised | shares
Options Outstanding, Cancelled | shares
Options Outstanding, Balance Ending | shares	24,942,045
Weighted-Average Exercise Price, Balance Beginning | $ / shares	$ 0.05
Weighted-Average Exercise Price, Grants | $ / shares	0.02
Weighted-Average Exercise Price, Exercised | $ / shares
Weighted-Average Exercise Price, Cancelled | $ / shares
Weighted-Average Exercise Price, Balance Ending | $ / shares	$ 0.03

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of Weighted Average Assumptions for Stock Options Granted (Details) - Stock Options [Member]	3 Months Ended
	Mar. 31, 2021
Expected term (years)	5 years 8 months 12 days
Expected stock price volatility	296.17%
Weighted-average risk-free interest rate	0.64%
Expected dividend	0.00%

Share-Based Compensation - Sc_3

Share-Based Compensation - Schedule of Stock Options Vested and Expected to Vest (Details)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Share-based Payment Arrangement [Abstract]
Number of Options, Outstanding | shares	24,942,045
Number of Options, Exercisable | shares	745,031
Number of Options, Expected to vest | shares	24,197,014
Weighted-Average Remaining Contractual Life (In Years), Outstanding	9 years 6 months 29 days
Weighted-Average Remaining Contractual Life (In Years), Exercisable	8 years 9 months 22 days
Weighted-Average Remaining Contractual Life (In Years), Expected to vest	9 years 7 months 6 days
Weighted-Average Exercise Price, Outstanding | $ / shares	$ 0.03
Weighted-Average Exercise Price, Exercisable | $ / shares	0.43
Weighted-Average Exercise Price, Expected to vest | $ / shares	$ 0.02

Share-Based Compensation - Sc_4

Share-Based Compensation - Schedule of Restricted Stock Activity (Details)	3 Months Ended
	Mar. 31, 2021$ / sharesshares
Number of Restricted Stock, Exercised
Restricted Stock [Member]
Number of Restricted Stock, Balance Beginning	14,712,760
Number of Restricted Stock, Shares of restricted stock granted	9,000,309
Number of Restricted Stock, Exercised
Number of Restricted Stock, Cancelled
Number of Restricted Stock, Balance Ending	23,713,069
Weighted-Average Fair Value of Restricted Stock, Balance Beginning | $ / shares	$ 0.02
Weighted-Average Fair Value of Restricted Stock, Shares of restricted stock granted | $ / shares	0.03
Weighted-Average Fair Value of Restricted Stock, Exercised | $ / shares
Weighted-Average Fair Value of Restricted Stock, Cancelled | $ / shares
Weighted-Average Fair Value of Restricted Stock, Balance Ending | $ / shares	$ 0.04

Share-Based Compensation - Sc_5

Share-Based Compensation - Schedule of Restricted Stock Awards (Details) - Restricted Stock [Member] - shares	3 Months Ended	12 Months Ended
	Mar. 31, 2021	Dec. 31, 2020
Number of Restricted Stock Awards, Vested	477,192	452,192
Number of Restricted Stock Awards, Non-vested	23,235,877	14,260,568

Related Party Transactions (Det

Related Party Transactions (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2021	Mar. 31, 2020	Dec. 31, 2020	Sep. 16, 2019
Notes payable	$ 2,699,266		$ 1,157,806
Due to related party	458,218		561,230
Repayment of notes payable	1,256,591	$ 203,245
Borrowings	65,250	83,204
Operating expenses	1,528,989	$ 1,546,052
CEO [Member]
Borrowings	47,000
Operating expenses	18,249
Repayment of debt	48,763
DMB Group LLC [Member]
Due to related party	458,218		561,230
Asset Purchase Agreement [Member] | DMB Group LLC [Member]
Notes payable	285,883		$ 405,382	$ 940,000
Due to related party				$ 97,689
Repayment of notes payable	119,499
Interest expenses	$ 5,485